Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

Share Price is delayed by 15 minutes
Get Live Data
134.00    1.00 (0.75%)
Bid:
133.00
Ask:
135.00
Spread: 2.00 (1.504%)
Market Cap: £126.23m
TRU Live PriceLast checked at - London Stock Exchange

Intraday Trufin Plc Share Chart

Share Buyback Programme

22 May 2025 07:00

RNS Number : 7591J
TruFin PLC
22 May 2025
 

 

LEI: 213800C2QPZFECSRZ964

22 May 2025

 

 

TruFin plc

 ("TruFin" or the "Company" or together with its subsidiaries "TruFin Group" or the "Group")

 

 

Share Buyback Programme

 

 

TruFin (AIM: TRU) is pleased to announce the commencement of a share buyback programme ("Share Buyback Programme") to purchase ordinary shares of £0.91 each in the capital of the Company ("Ordinary Shares") up to a maximum aggregate consideration of £4 million (the "Maximum Amount").

 

As announced in the Group's trading update on 20 May 2025, the Share Buyback Programme is being initiated due to the Board's belief that the Company's shares trade at a discount to an internally calculated intrinsic value, in order to further enhance shareholder returns and to reduce the Company's share capital. Any Ordinary Shares acquired as a result of the Share Buyback Programme will be cancelled.

 

Details of the Buyback

 

The Group has entered into an agreement with its broker Panmure Liberum Limited ("Panmure Liberum") to carry out purchases of its Ordinary Shares under the Share Buyback Programme on its behalf. Panmure Liberum will manage the purchases on a discretionary basis, purchasing Ordinary Shares on the London Stock Exchange within certain pre-set parameters over the Share Buyback Programme up to the Maximum Amount.

 

Prior to the Company's next annual general meeting to be held on 12 June 2025 (the "2025 AGM"), the Share Buyback will take place within the limitations of the authority granted to the Board of TruFin at its annual general meeting ("General Authority"), held on 5 June 2024 (the "2024 AGM"), pursuant to which the maximum number of Ordinary Shares which may be bought back is 10,598,688, representing 10 per cent. of the Company's issued share capital. Thereafter, provided the relevant resolution is approved at the 2025 AGM, this limit will increase to 15,898,003, representing 15 per cent. of the Company's issue share capital.

 

In line with the authority given at the 2024 AGM, and the authority proposed at the 2025 AGM, the maximum price (exclusive of expenses) which may be paid for an Ordinary Share shall not be more than an amount equal to 105% of the average middle market quotations for an Ordinary Share, as derived from London Stock Exchange Daily Official List, for the five business days immediately preceding the day on which the Ordinary Share is contracted to be purchased.

 

Shareholders should be aware that the Share Buyback Programme may on any given trading day represent a significant portion of the daily traded volume in the Group's Ordinary Shares on the London Stock Exchange, and may exceed 25% (but not 50%) of the average daily traded volume on the London Stock Exchange during the 20 trading days preceding the date of purchase of such Ordinary Shares (the "Volume Limit"). Accordingly, the Group may not benefit from the exemption contained in Article 5(1) of MAR. The Volume Limit may be exceeded should Panmure Liberum consider, at its discretion, that an opportunity has arisen to acquire a significant number of shares in one trade. In such circumstances, an announcement of the purchase will be made as soon as possible following such trade taking place.

 

The Group has authorised the Share Buyback Programme to commence from today and will continue until the earlier of: (i) the date on which the Maximum Amount payable by the Company has been reached, or (ii) 31 August 2025, conditional on the share buyback authority being renewed at the Company's 2025 AGM.

 

Any market purchase of Ordinary Shares pursuant to the Share Buyback Programme will be announced no later than 7:30am (UK time) on the business day following the day on which the purchase occurred.

 

 

For further information, please contact:

 

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

 

0203 743 134007779 229508

 

Panmure Liberum Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward Thomas

 

0203 100 2000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEWSIEEISEFI
Date   Source Headline
9th Jun 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Jun 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Jun 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jun 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
30th May 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
28th May 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd May 20257:00 amRNSShare Buyback Programme
20th May 202512:03 pmRNSHolding(s) in Company
20th May 20257:00 amRNSTrading Update and Share Buyback
13th May 20257:00 amRNSNotice of AGM
1st May 20252:42 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSBlock Admission Six Monthly Return
10th Apr 20257:00 amRNSCEO Incentive Plan
26th Mar 20257:00 amRNSFinal Results for the 12 months ended 31 Dec 2024
19th Mar 20257:00 amRNSNotice of Results and Investor Presentation
28th Feb 20257:00 amRNSTotal Voting Rights
16th Jan 20257:32 amRNS-RAnnouncement of partnership between Satago and DFC
6th Jan 20257:00 amRNSTrading Statement
6th Dec 20247:00 amRNSDirector/PDMR Shareholding
5th Dec 20247:00 amRNSTrading Statement
29th Nov 20247:00 amRNSTotal Voting Rights
18th Nov 20247:00 amRNSTrading Statement
17th Oct 20247:00 amRNSBlock Admission Six Monthly Return
17th Sep 20247:00 amRNSHalf-year Report
29th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
29th Jul 20247:00 amRNSAppointment of Vicki Sloane as CEO of Oxygen
18th Jul 20247:00 amRNSSatago wins contract with UK Specialist Lender
17th Jul 202410:13 amRNSDirector/PDMR Shareholding
16th Jul 202410:34 amRNSDirector/PDMR Shareholding
16th Jul 20247:00 amRNSSatago – Update re Lloyds Commercial Agreement
1st Jul 20247:00 amRNSNominated Adviser and Broker
28th Jun 20242:06 pmRNSHolding(s) in Company
27th Jun 20247:00 amRNSPlaystack Platform Contract
5th Jun 202410:08 amRNSResult of AGM
31st May 20247:00 amRNSTotal Voting Rights
20th May 20247:00 amRNSOxygen Finance wins early payment clients
13th May 20247:00 amRNSTrading Statement
2nd May 20245:49 pmRNSNotice of AGM
12th Apr 20247:01 amRNSBlock Admission Application
12th Apr 20247:00 amRNSGrant of share awards under LTIP
2nd Apr 20247:00 amRNSAppointment of Director to the Board of Playstack
26th Mar 20247:01 amRNSSale of Interact platform
25th Mar 20247:00 amRNSSatago signs contract with Bank of Ireland Finance
19th Mar 20247:00 amRNSNotice of Results and Investor Presentation
18th Mar 20247:00 amRNSPlaystack announces over 1m units sold for Balatro
12th Mar 202411:07 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSPlaystack releases its fastest selling game
8th Feb 20247:00 amRNSTrading Update
4th Jan 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.